Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Masanori P TakahashiClinical Neurophysiology, Department of Clinical Laboratory and Biomedical Sciences, The University of Osaka Graduate School of Medicine, Yamadaoka, Suita 565-0871, Osaka, Japan.ORCID 0000-0002-5513-5012
Harutsugu TatebeInstitute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.
Hiroto TakadaDepartment of Neurology, NHO Aomori National Hospital, Aomori 038-1331, Japan.ORCID 0000-0003-0381-2904
Takahiro NakayamaDepartment of Neurology, Division of Neuromuscular Diseases, Yokohama Rosai Hospital, Yokohama 222-0036, Kanagawa, Japan.
Michio KobayashiDepartment of Neurology, NHO Akita National Hospital, Yurihonjo 018-1301, Akita, Japan.ORCID 0000-0001-6156-4713
Kosuke YoshidaDepartment of Neurology, NHO Asahikawa Medical Center, Asahikawa 070-8644, Hokkaido, Japan.
Satoshi KuruDepartment of Neurology, NHO Suzuka National Hospital, Suzuka 513-0004, Mie, Japan.ORCID 0000-0002-1149-4881
Natsuki KiraClinical Neurophysiology, Department of Clinical Laboratory and Biomedical Sciences, The University of Osaka Graduate School of Medicine, Yamadaoka, Suita 565-0871, Osaka, Japan.
Tomoya KubotaClinical Neurophysiology, Department of Clinical Laboratory and Biomedical Sciences, The University of Osaka Graduate School of Medicine, Yamadaoka, Suita 565-0871, Osaka, Japan.
Yasuaki MizutaniDepartment of Neurology, Fujita Health University School of Medicine, Toyoake 470-1192, Aichi, Japan.
Hirohisa WatanabeDepartment of Neurology, Fujita Health University School of Medicine, Toyoake 470-1192, Aichi, Japan.ORCID 0000-0001-8553-8536
Yuhei TakadoInstitute for Quantum Life Science, National Institutes for Quantum Science and Technology, Chiba 263-8555, Japan.ORCID 0000-0001-7484-8424
Takahiko TokudaDepartment of Neuroetiology and Diagnostic Science, Healthy Longevity Medicine, Osaka Metropolitan University Graduate School of Medicine, Suita 545-8585, Osaka, Japan.
Funding
Japan Agency for Medical Research and Development JP22ek0109474Japan Agency for Medical Research and Development JP25ek0109619Ministry of Health and Welfare of Japan 24FC1009National Center for Neurology and Psychiatry 5-5
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
amyloid-betabiomarkerbloodmyotonic dystrophyneurofilament light chainphosphorylated tau
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Plasma Neurofilament Light Chain and Phosphorylated Tau Are Elevated in Myotonic Dystrophy Type 1. · full record | Socratic